Infection and coronary heart disease

Journal of Medical Microbiology

Volumn 46, Issue 7, 1997, Pages 535-539

  Ellis, R W ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ATHEROGENESIS; ATHEROSCLEROSIS; AVIAN LYMPHOMATOSIS HERPETOVIRUS; BACTERIAL INFECTION; CHLAMYDOPHILA PNEUMONIAE; COXSACKIE VIRUS B4; CYTOMEGALOVIRUS; HEART MUSCLE ISCHEMIA; HELICOBACTER PYLORI; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; ISCHEMIC HEART DISEASE; LIPID METABOLISM; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEROEPIDEMIOLOGY; VIRUS INFECTION;

EID: 0030855535     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/00222615-46-7-535     Document Type: Review

References (44)

1. Spodick DH, Flessas AP, Johnson MM. Association of acute respiratory symptoms with onset of acute myocardial infarction: prospective investigation of 150 consecutive patients and matched control patients. Am J Cardiol 1984; 53: 481-482.
2. Burch GE, Shewey LL. Viral coronary arteritis and myocardial infarction. Am Heart J 1976; 92: 11-14.
3. Abe J, Kotzin BL, Jujo K et al. Selective expansion of T cells expressing T-cell receptor variable regions Vβ2 and Vβ8 in Kawasaki disease. Proc Natl Acad Sci USA 1992; 89: 4066-4070.
4. 4-infected mice. Lab Invest 1968; 19: 399-405.
5. Nicholls AC, Thomas M. Coxsackie virus infection in acute myocardial infarction. Lancet 1977; 1: 883-884.
6. Woods JD, Nimmo MJ, Mackay-Scollay EM. Acute transmural myocardial infarction associated with active Coxsackie virus B infection. Am Heart J 1975; 89: 283-287.
7. Wood SF, Rogen AS, Bell EJ, Grist NR. Role of Coxsackie B viruses in myocardial infarction. Br Heart J 1978; 40: 523-525.
8. O'Neill D, McArthur JD, Kennedy JA, Clements G. Coxsackie B virus infection in coronary care unit patients. J Clin Pathol 1983; 36: 658-661.
9. Benditt EP, Benditt JM. Evidence for a monoclonal origin of human atherosclerotic plaques. Proc Natl Acad Sci USA 1973; 70: 1753-1756.
10. Fabricant CG, Fabricant J, Minick CR, Litrenta MM. Herpesvirus-induced atherosclerosis in chickens. Fed Proc 1983; 42: 2476-2479.
11. Benditt EP, Barrett T, McDougall JK. Viruses in the etiology of atherosclerosis. Proc Natl Acad Sci USA 1983; 80: 6386-6389.
12. Yamashiroya HM, Ghosh L, Yang R, Robertson AL. Herpesviridae in the coronary arteries and aorta of young trauma victims. Am J Pathol 1988; 130: 71-79.
13. Petrie BL, Melnick JL, Adam E, Bureck J, McCollum CH, DeBakey ME. Nucleic acid sequence of cytomegalovirus in cells cultured from human arterial tissue. J Infect Dis 1987; 155: 158-159.
14. Gyorkey F, Melnick JL, Guinn GA, Gyorkey P, DeBakey ME. Herpesviridae in the endothelial and smooth muscle cells of the proximal aorta of atherosclerosis patients. Exp Mol Pathol 1984; 40: 328-339.
15. Hendricks MGR, Salimens MMM, Vauboven CPA, Bruggeman CA. High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis. Am J Pathol 1990; 136: 23-28.
16. Speir E, Modali R, Huang E-S et al. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 1994; 265: 391-394.
17. Dummer S, Lee A, Breinig MK, Kormos R, Ho M, Griffith B. Investigation of cytomegalovirus infection as a risk factor for coronary atherosclerosis in the explanted hearts of patients undergoing heart transplantation. J Med Virol 1994; 44: 305-309.
18. Kol A, Sperti G, Shani J et al. Cytomegalovirus replication is not a cause of instability in unstable angina. Circulation 1995; 91: 1910-1913.
19. Ventura HO, Mehra MR, Smart FW, Stapleton DD. Cardiac allograft vasculopathy: current concepts. Am Heart J 1995; 129: 791-798.
20. Normann SJ, Salomon DR, Leelachaikul P et al. Acute vascular rejection of the coronary arteries in human heart transplantation: pathology and correlations with immunosuppression and cytomegalovirus infection. J Heart Lung Transplant 1991; 10: 674-687.
21. Koskinen PK, Nieminen MS, Krogerus LA et al. Cytomegalovirus infection and accelerated cardiac allograft vasculopathy in human cardiac allografts. J Heart Lung Transplant 1993; 12: 724-729.
22. Koskinen PK, Nieminen MS, Krogerus LA et al. Cytomegalovirus infection accelerates cardiac allograft vasculopathy: correlation between angiographic and endomyocardial biopsy findings in heart transplant patients. Transpl Int 1993; 6: 341-347.
23. Etingin OR, Silverstein RL, Friedman HM, Hajjar DP. Viral activation of the coagulation cascade: molecular interactions at the surface of infected endothelial cells. Cell 1990; 61: 657-662.
24. Hajjar DP, Pomerantz KB, Falcone DJ, Weksler BB, Grant AJ. Herpes simplex virus infection in human arterial cells: implications in atherosclerosis. J Clin Invest 1987; 80: 1317-1321.
25. Visser MR, Tracy PB, Vercellotti GM, Goodman JL, White JG, Jacobs HS. Enhanced thrombin generation and platelet binding on herpes simplex virus-infected endothelium. Proc Natl Acad Sci USA 1988; 85: 8227-8230.
26. Penn A, Garte SJ, Warren L, Nesta D, Mindich B. Transforming gene in human atherosclerotic plaque DNA. Proc Natl Acad Sci USA 1986; 83: 7951-7955.
27. Marrie TJ. Chlamydia pneumoniae. Thorax 1993; 48: 1-4.
28. Saikku P, Mattila K, Nieminen MS et al. Serological evidence of an association of a novel chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988; ii: 983-985.
29. Saikku P, Leinonen M, Tenkanen L et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med 1992; 116: 273-278.
30. Thom DH, Wang SP, Grayston JT et al. Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease. Arterioscler Thromb 1991; 11: 547-551.
31. Thom DH, Grayston JT, Siscovick DS, Wang S-P, Weiss NS, Daling JR. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA 1992; 268: 68-72.
32. Patel P, Mendall MA, Carrington D et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ 1995; 311: 711-714.
33. Kuo C-C, Shor A, Campbell LA, Fukushi A, Patton DL, Grayston JT. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis 1993; 167: 841-849.
34. Wang S-P, Grayston JT. Population prevalence of antibody to Chlamydia pneumoniae strain TWAR. In: Bowie WR, Caldwell HD, Jones RP et al (eds) Chlamydial infections. Cambridge, Cambridge University Press, 1990: 402-405.
35. Mendall MA, Goggin PM, Molineaux N et al. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 1994; 71: 437-439.
36. Cunningham A, Ward M, Matthews R, Ellis R. Helicobacter pylori and Chlamydia pneumoniae in tissues of myocardial infarction cases. 1st European Congress of Chemotherapy, Glasgow. 1996: Abstract W149.
37. Alvarez C, Ramos A. Lipids, lipoproteins, and apoproteins in serum during infection. Clin Chem 1986; 32: 142-145.
38. Lopes-Virella MF. Interactions between bacterial lipopolysaccharides and serum lipoproteins and their possible role in coronary heart disease. Eur Heart J 1994; 14 Suppl K: 118-124.
39. Nieminen MS, Mattila K, Valtonen V. Infection and inflammation as risk factors for myocardial infarction. Eur Heart J 1993; 14 Suppl K: 12-16.
40. Reines HD, Halushka PV, Cook JA, Wise WC, Rambo W. Plasma thromboxane concentrations are raised in patients dying with septic shock. Lancet 1982; 2: 174-175.
41. Patel P, Carrington D, Strachan DP et al. Fibrinogen: a link between chronic infection and coronary heart disease. Lancet 1994; 343: 1634-1635.
42. Yarnell JWG, Baker IA, Sweetman PM et al. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies. Circulation 1991; 83: 836-844.
43. Liuzzo G, Biasucci LM, Gallimore JR et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994; 331: 417-424.
44. Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC. C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ 1996; 312: 1061-1065.